Alpenglow Biosciences
Alpenglow Biosciences provides AI-enabled 3D tissue imaging, digital pathology, and spatial profiling solutions for researchers and clinical teams. Its platform combines light-sheet microscopy, automated volumetric data processing, and AI-powered analysis to quantify cells, structures, and spatial relationships in intact tissue samples, supporting drug development, diagnostics, and biomarker discovery. The organization aims to advance biological insight and clinical diagnostics by enabling comprehensive analysis of tissue biology.
Facts
- HQ
- Seattle, Washington, USA
- Sectors
- Biotechnology Research
- Founded
- 2018
- Employees
- 50
- Registered name
- Alpenglow Biosciences
- Members see funding amounts. .
- Founders
- Nicholas Reder, Jonathan Liu, Adam Glaser, Larry True
Is this your organization? Claim it
GeekWire 2026 Innovation of the Year Finalists Include Alpenglow Biosciences and Pacific Northwest National Laboratory
The 2026 GeekWire Awards announced finalists for Innovation of the Year, including Alpenglow Biosciences, Pacific Northwest National Laboratory, RevealDx, Starcloud, and VerAvanti, recognized for breakthroughs in healthcare and data center technology. The awards event will be held on May 7 in Seattle, with public voting open through April 10.
Alpenglow Biosciences Partners with PathNet to Commercialize 3D Microscope Tech for Cancer Diagnostics with $250K Funding
Seattle-based Alpenglow Biosciences partnered with PathNet to commercialize its 3D microscope technology for cancer diagnostics, focusing on prostate and bladder cancers. The startup also secured $250,000 in funding from Mike Rice to support regulatory validation and clinical application development.
Phase Genomics Secures $2.5M to Develop AI Platform for Detecting Cancer Chromosomal Aberrations
Seattle startup Phase Genomics received $2.5 million in funding, including $2 million from the U.S. National Cancer Institute and $500,000 from Washington state's Andy Hill CARE Fund, to advance its AI-driven platform that detects chromosomal aberrations in cancer. The funding supports projects analyzing tumor samples to develop predictive scores for cancers like acute myeloid leukemia and colorectal cancer.
People
See all 4-
Nicholas Reder Executive Officer, Director, CEO, Founder & Co-Inventor
-
Adam Glaser Co-founder
-
Jonathan Liu Co-founder
Online
Questions about Alpenglow Biosciences
What is Alpenglow Biosciences?
Alpenglow Biosciences is a startup based in Seattle, Washington, USA that provides AI-enabled 3D tissue imaging, digital pathology, and spatial profiling for researchers and clinical teams.
What is Alpenglow Biosciences known for?
Alpenglow Biosciences combines light-sheet microscopy, automated volumetric data processing, and AI analysis to quantify cells, structures, and spatial relationships in intact tissue for drug development, diagnostics, and biomarker discovery.
What has Alpenglow Biosciences been in the news for?
GeekWire reported in March 2026 that Alpenglow Biosciences was among its Innovation of the Year finalists. In January 2026, GeekWire reported that Alpenglow Biosciences partnered with PathNet to commercialize 3D microscope technology for cancer diagnostics.
Who are the people behind Alpenglow Biosciences?
Nicholas Reder is CEO, executive officer, founder and co-inventor of Alpenglow Biosciences. Adam Glaser, Jonathan Liu and Lawrence True are co-founders.
Who invested in Alpenglow Biosciences, and how much has it raised?
Members of Seattle Flow see Alpenglow Biosciences' funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is Alpenglow Biosciences based?
Alpenglow Biosciences is based in Seattle, Washington, USA.